文献速递神经创伤神经重症

伤前使用抗血小板药和抗凝药对老年中重度创伤性脑损伤合并创伤性急性硬膜下血肿患者的影响

The Impact of Preinjury Antiplatelet and Anticoagulant Use on Elderly Patients with Moderate or Severe Traumatic Brain Injury Following Traumatic Acute Subdural Hematoma.
PubMed 文献 · World Neurosurg · 2022-07-14

本研究基于一级创伤中心登记资料,纳入2013年1月1日至2018年1月1日连续收治的132例年龄≥65岁、中重度创伤性脑损伤合并创伤性急性硬膜下血肿患者,比较伤前使用抗血小板药、抗凝药、两者联合及未使用抗血栓药组之间急性硬膜下血肿厚度、30天死亡率和6个月扩展格拉斯哥结局量表不良结局的差异。结果显示各组急性硬膜下血肿平均厚度存在统计学显著差异,但30天死亡率(P=0.732)和不良结局(P=0.342)无显著差异。

要点

  • 132例年龄≥65岁中重度创伤性脑损伤合并急性硬膜下血肿患者纳入分析,平均年龄78.39(±7.87)岁。
  • 抗血小板药、抗凝药、联合用药及未用药组间30天死亡率无显著差异(P=0.732)。
  • 各组6个月不良结局无显著差异(P=0.342),但急性硬膜下血肿平均厚度存在统计学显著差异。

核心结论

  • 研究结果不支持临床实践中认为抗血栓药使用与老年中重度创伤性脑损伤患者不良结局相关的先入观念,但需更大样本研究进一步证实。

研究设计与样本

  • 一级创伤中心登记资料的队列研究,连续纳入2013年1月1日至2018年1月1日收治的年龄≥65岁、中重度创伤性脑损伤合并创伤性急性硬膜下血肿患者,共132例。

主要发现

  • 132例患者平均年龄78.39(±7.87)岁,男性占59.8%(n=79)。
  • 抗血小板药、抗凝药、联合用药及未使用抗血栓药组间急性硬膜下血肿平均厚度存在统计学显著差异。
  • 各组30天死亡率无显著差异(P=0.732),6个月不良结局无显著差异(P=0.342)。

关键数值与推荐

  • 主要结局指标为初始CT上急性硬膜下血肿厚度、30天死亡率及6个月不良结局(扩展格拉斯哥结局量表)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需更大样本量的进一步研究来证实这些观察结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although it is often assumed that preinjury anticoagulant (AC) or antiplatelet (AP) use is associated with poorer outcomes among those with acute subdural hematoma (aSDH), previous studies have had varied results. This study examines the impact of preinjury AC and AP therapy on aSDH thickness, 30-day mortality, and extended Glasgow Outcome Scale at 6 months in elderly patients (aged ≥65). METHODS: A level 1 trauma center registry was interrogated to identify consecutive elderly patients who presented with moderate or severe traumatic brain injury (TBI) and associated traumatic aSDH between the first of January 2013 and the first of January 2018. Relevant demographic, clinical, and radiological data were retrieved from institutional medical records. The 3 primary outcome measures were aSDH thickness on initial computed tomography scan, 30-day mortality, and unfavorable outcome at 6 months (extended Glasgow Outcome Scale). RESULTS: One hundred thirty-two elderly patients were admitted with moderate or severe TBI and traumatic aSDH. The mean (±SD) age was 78.39 (±7.87) years, and a majority of patients (59.8%, n = 79) were male. There was a statistically significant difference in mean aSDH thickness, but there were no significant differences in 30-day mortality (P = 0.732) and unfavorable outcome between the AP, AC, combined AP and AC, and no antithrombotic exposure groups (P = 0.342). CONCLUSIONS: Further studies with larger sample sizes are necessary to confirm these observations, but our findings do not support the preconceived notion in clinical practice that antithrombotic use is associated with poor outcomes in elderly patients with moderate or severe TBI.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. O'Donohoe RB, Lee HQ, Tan T, et al. The Impact of Preinjury Antiplatelet and Anticoagulant Use on Elderly Patients with Moderate or Severe Traumatic Brain Injury Following Traumatic Acute Subdural Hematoma. World Neurosurg. 2022. PMID: 35843581. doi:10.1016/j.wneu.2022.07.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。